CVS HEALTH CORPORATION (CVS) FY2025 Q2 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2025 Q2 P&L / Income Statement

Income statement for 2025-04-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

98,915,000,000 US dollars

Total operating costs

96,534,000,000 US dollars

Operating income

2,381,000,000 US dollars

Other income (expense), net (calculated)

negative 734,000,000 US dollars

Income before income tax provision

1,647,000,000 US dollars

Income tax provision

634,000,000 US dollars

Net income

1,013,000,000 US dollars

Health Care Benefits

36,258,000,000 US dollars

Health Services

46,453,000,000 US dollars

Pharmacy & Consumer Wellness

33,581,000,000 US dollars

Cost of products sold

54,005,000,000 US dollars

Health care costs

31,317,000,000 US dollars

Operating expenses

11,212,000,000 US dollars

Revenue before reconciliation (calculated)

116,292,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Health Care Benefits

negative 20,000,000 US dollars. Reported reconciliation to consolidated revenue.

Health Services

negative 6,338,000,000 US dollars. Reported reconciliation to consolidated revenue.

Pharmacy & Consumer Wellness

negative 11,115,000,000 US dollars. Reported reconciliation to consolidated revenue.

Corporate/ Other

96,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to CVS HEALTH CORPORATION: $1.02 B; to noncontrolling interests: −$8.00 M.